These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29471778)

  • 1. Evaluation of Uracil, Sodium Ascorbate, and Rosiglitazone as Promoters of Urinary Bladder Transitional Cell Carcinomas in Male Sprague-Dawley Rats.
    Tirmenstein M; Janovitz E; Dorr T; Song Y; Chen SJ; Granaldi K; Chadwick KD; Mangipudy R; Graziano M; Attalla B; Haile S; Czajkowski M; Foster JR; Bergholm AM; Billger M; Söderberg M
    Toxicol Pathol; 2018 Feb; 46(2):147-157. PubMed ID: 29471778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
    Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
    Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
    Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B; Jeney A; Institoris L
    Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F344/Shi rats bearing type b catalase-1 locus are sensitive to sodium L-ascorbate promotion of two-stage urinary bladder carcinogenesis.
    Mori S; Murai T; Hosono M; Yamashita H; Oohara T; Makino S; Doteuchi M; Fukushima S
    Teratog Carcinog Mutagen; 1998; 18(1):27-33. PubMed ID: 9586768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
    Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
    Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil.
    de Oliveira ML; Souza Rocha N; Fukushima S; de Camargo JL
    Teratog Carcinog Mutagen; 1995; 15(4):191-9. PubMed ID: 8838633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil-induced calculi and carcinogenesis in the urinary bladder of rats treated simultaneously with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okumura M; Shirai T; Tamano S; Ito M; Yamada S; Fukushima S
    Carcinogenesis; 1991 Jan; 12(1):35-41. PubMed ID: 1988179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
    Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Billger M; Kirk J; Chang J; Bédard A; Attalla B; Haile S; Söderberg M
    Regul Toxicol Pharmacol; 2019 Apr; 103():166-173. PubMed ID: 30685222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
    Kunze E; Schulz H; Adamek M; Gabius HJ
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong promoting activity by uracil on urinary bladder carcinogenesis and a possible inhibitory effect on thyroid tumorigenesis in rats initiated with N-methyl-N-nitrosourea.
    Masui T; Mann AM; Garland EM; Cohen SM
    Carcinogenesis; 1989 Aug; 10(8):1471-4. PubMed ID: 2752521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats.
    Fukushima S; Imaida K; Sakata T; Okamura T; Shibata M; Ito N
    Cancer Res; 1983 Sep; 43(9):4454-7. PubMed ID: 6871876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N; Fukushima S; Shirai T; Hagiwara A; Imaida K
    IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.